Lexaria Bioscience (LXX.C) has received test results for two new DehydraTECH 2.0 cannabidiol (CBD) formulations in its second 2021 applied research and development study program, HYPER-A21-2. Read full article here: https://equity.guru/2021/05/20/lexaria-biosciences-lxx-c-dehydratech-2-0-exceeds-predecessor/